ホーム>>Lipids>> Lipid-Based Drug Delivery>>1,2-Dihexadecyl-sn-glycero-3-PC

1,2-Dihexadecyl-sn-glycero-3-PC (Synonyms: 1,2-Dihexadecyl-sn-glycero-3-Phosphocholine)

カタログ番号GC18275

1,2-ジヘキサデシル-sn-グリセロ-3-PCは、sn-1およびsn-2位置にヘキサデシル基を含む合成エーテル結合型のリン脂質です。

Products are for research use only. Not for human use. We do not sell to patients.

1,2-Dihexadecyl-sn-glycero-3-PC 化学構造

Cas No.: 36314-47-3

サイズ 価格 在庫数 個数
50mg
$79.00
在庫あり
100mg
$142.00
在庫あり
250mg
$309.00
在庫あり
500mg
$541.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Background

1,2-ジヘキサデシル-sn-グリセロ-3-PCは、sn-1およびsn-2位置にヘキサデシル基を含む合成エーテル結合型のリン脂質です。この化合物は、脂質体や人工的な膜の生成に一般的に使用され、膜ダイナミクスの研究に用いられます。

Chemical Properties

Cas No. 36314-47-3 SDF
同義語 1,2-Dihexadecyl-sn-glycero-3-Phosphocholine
Chemical Name (7R)-7-(hexadecyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphapentacosan-1-aminium, 4-oxide, inner salt
Canonical SMILES [O-]P(OC[C@H](OCCCCCCCCCCCCCCCC)COCCCCCCCCCCCCCCCC)(OCC[N+](C)(C)C)=O
Formula C40H84NO6P M.Wt 706.1
溶解度 Ethanol: 30 mg/ml Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.4162 mL 7.0811 mL 14.1623 mL
5 mM 0.2832 mL 1.4162 mL 2.8325 mL
10 mM 0.1416 mL 0.7081 mL 1.4162 mL
  • モルアリティ計算機

  • 希釈計算機

質量
=
濃度
x
容積
x
MW*
 
 
 
**ストックソリューションを準備する際には、常にバイアルラベルおよび MSDS/CoA(オンラインで利用可能)で掲載された製品のロット固有分子量を使用してください。

計算

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

レビュー

Review for 1,2-Dihexadecyl-sn-glycero-3-PC

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1,2-Dihexadecyl-sn-glycero-3-PC

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.